Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
1,398,623
-
Shares change
-
+581,200
-
Total reported value, excl. options
-
$161,120,204
-
Value change
-
+$67,555,899
-
Put/Call ratio
-
19%
-
Number of buys
-
33
-
Number of sells
-
-27
-
Price
-
$115.20
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2016
86 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q3 2016.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,398,623 shares
.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (597,816 shares), GOLDMAN SACHS GROUP INC (101,903 shares), UBS Group AG (80,191 shares), MORGAN STANLEY (74,360 shares), MURPHY CAPITAL MANAGEMENT INC (46,862 shares), ROYAL BANK OF CANADA (39,551 shares), BANQUE PICTET & CIE SA (33,500 shares), Cambridge Investment Research Advisors, Inc. (28,932 shares), Timber Hill LLC (27,360 shares), and Strategic Financial Services, Inc, (27,177 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.